Recently, the detection model of CTCs based on the expression of EpCAM, MUC1, and Wilms tumor protein WT1 showed significantly higher specificity than CA125 (92% vs. 82%), especially in early-stage ovarian cancer (74% vs. 58%). The gene discussed is WT1; the disease is ovarian carcinoma.